IMPLANT SITE DERMATITIS

IMPLANT SITE DERMATITIS was reported 18 times

These drug classes are most commonly taken by patients reporting IMPLANT SITE DERMATITIS:

# Drug Count
0 Progestin [EPC] 10
1 Complement Inhibitor [EPC] 1
2 Leukocyte Growth Factor [EPC] 1
3 Platinum-based Drug [EPC] 1
4 Serotonin Reuptake Inhibitor [EPC] 1